Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 3Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Weight Loss 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Malnutrition 1Insulin Resistance 1Hyperbilirubinemia 1Hyperandrogenism 1Hirsutism 1Heart Failure 1Gastrointestinal Stromal Tumors 1Fatigue 1Dyslipidemias 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Cachexia 1Basal Cell Nevus Syndrome 1

Interventions

Radiotherapy 4Paclitaxel 4Carboplatin 4Sodium Chloride 3Oxaliplatin 3Cyclophosphamide 3Vincristine 2Surveys and Questionnaires 2Procarbazine 2Prednisolone 2Methotrexate 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Magnesium Sulfate 2Leucovorin 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2Cytarabine 2Calcium Gluconate 2Amifostine 2Acupuncture Therapy 2neurotropin 1motexafin gadolinium 1haloperidol decanoate 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurotoxicity Syndromes × Carnitine × Clear all
NCT00754767 2017-09-11

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

HealthPartners Institute

Phase 4 Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡